Navigation Links
Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
Date:6/12/2008

PARIS, June 13 /PRNewswire-FirstCall/ -- Abbott announced new data from the open-label extension of the ATLAS (Adalimumab Trial Evaluating Long-Term Efficacy and Safety in AS) phase III clinical trial, which showed HUMIRA(R) (adalimumab) reduced the signs and symptoms of ankylosing spondylitis (AS) for up to three years of treatment among 74 percent of patients tested. AS is a type of arthritis that primarily causes inflammation of the spine and the spinal joints. These data were presented at the European League Against Rheumatism (EULAR) annual meeting in Paris.

"There is no cure for ankylosing spondylitis and the goal of therapy is to relieve back and joint pain," said Desiree van der Heijde, M.D., co-lead investigator of ATLAS and Professor of Rheumatology at Leiden University Medical Center, The Netherlands. "Even partial remission of AS can have a considerable positive impact on a patient's symptoms. These data are reassuring for patients because they demonstrate that adalimumab can be an effective treatment for ankylosing spondylitis."

Three-Year ATLAS Data Summary

ATLAS was a randomized, placebo-controlled, double-blind, Phase III study conducted in the U.S. and Europe. The study involved 315 patients with active AS who had an inadequate response to at least one non-steroidal anti-inflammatory drug (NSAID) or disease modifying anti-rheumatic drug (DMARD). Patients received HUMIRA 40mg subcutaneously or placebo every other week (EOW). Results at 12 and 24 weeks showed HUMIRA patients experienced a statistically significant reduction in signs and symptoms according to the Assessment in SpondyloArthritis International Society (ASAS) measure, or ASAS20 compared to placebo. ASAS20 represents at least a 20 percent improvement in at least three of the four assessments to measure patient improvement and response to therapy. At 24 weeks, all patients were switched to an open-label HUMIRA 40mg EOW dose trial for an additional 236 weeks. Impr
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
2. Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
3. Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
4. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
5. The CoverMe Foundation Offers Free, Step-By-Step Assistance to Connect Uninsured with Free or Reduced-Cost Health Care
6. Family history of colorectal cancer linked with reduced risk of cancer recurrence
7. Hot Flashes Reduced by Neck Injection
8. Ibuprofen Linked to Reduced Alzheimers Risk
9. Reduced emergency room visits for elderly patients attributed to virtual health care team approach
10. Autistic mannerisms reduced by sensory treatment
11. Competing San Francisco Bay Area Hospitals Demonstrate That Collaborative Efforts Contribute to Reduced Hospital Errors and Saved Lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html ... latest update involving allegations that the use of ... can allegedly cause potentially fatal irregular heart ... May 17, 2013* that Health Canada has joined ... that Zithromax can cause abnormal changes in the ...
(Date:5/24/2013)... May 24, 2013 Scott Ryan Tischler ... Troy Tischler, lose 200 lbs. of fat in just ... teach his younger brother the importance of exercising. Scott ... By sticking to these 7 rules of healthy eating ... goals can be accomplished. , 1.    Find a distraction when ...
(Date:5/24/2013)... 2013 Psoriasis treatment cream has been ... This new FDA registered company is now offering its ... appearance of Psoriasis infected skin. , Dermasis has launched ... online. This soothing cream is designed to offer immediate ... and appearance of red skin often caused by psoriasis ...
(Date:5/23/2013)... FL (PRWEB) May 24, 2013 ... the Cellulite Whisperer line, with a ... for Summer Sale" includes two proprietary products, the ... Whisperer® Lotion . , Purchasers receive a report ... , "The Gel has a wonderful grapefruit scent," ...
(Date:5/23/2013)... Plantation, FL (PRWEB) May 24, 2013 ... and coaching educators in tennis for over 29 years, ... more than 50 ATP & WTA players, Grand Slam ... and Italian Open Champions, 25 USTA National Junior Champions, ... ITF Junior Champions, including Sunshine Cup, Orange Bowl and ...
Breaking Medicine News(10 mins):Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:Internationally Respected Tennis Coach, Nick Saviano Opens Summer Training Registration 2
... -- A study in the December issue of the ... why death rates for less educated middle aged adults are ... awareness and treatments aimed at reducing health disparities. For ... education levelsthat is high school or lessare twice as likely ...
... HealthDay Reporter , WEDNESDAY, Dec. 14 (HealthDay News) -- Every ... rape, physical violence, or stalking by an intimate partner, according ... to data from the U.S. Centers for Disease Control and ... of partner violence each year, with by far the biggest ...
... ,Headache affects 50 percent of HIV/AIDS patients in the United ... study says. About 27.5 percent of the 200 HIV/AIDS ... in which a person has migraine symptoms (with or without ... condition occurs in only 2 percent of the general population. ...
... diagnosed with locally-advanced pancreatic cancer in the United States ... these patients whose tumor has grown beyond the pancreas ... years, numerous treatment regimens have been evaluated for locally-advanced ... the current standard approach. However, the median survival time ...
... developing countries rely on traditional medicine as an accessible ... now, scientific data has not existed to evaluate the ... from the William L. Brown Center of the Missouri ... brine shrimp to determine the toxicity of 341 Northern ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Dec. ... that prevents them from sensing or reacting to anything ... a plate or recognizing a person sitting to that side ... cells in their brain, Italian researchers report. This inability ...
Cached Medicine News:Health News:Study takes aim at education-based death rate disparities 2Health News:Millions of Americans Are Victims of Sexual Violence: CDC 2Health News:Millions of Americans Are Victims of Sexual Violence: CDC 3Health News:Headaches May Plague Many With HIV/AIDS 2Health News:RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer 2Health News:Missouri Botanical Garden scientists examine toxicity of medicinal plants in Peru 2Health News:Missouri Botanical Garden scientists examine toxicity of medicinal plants in Peru 3Health News:Magnetic Brain Stimulation Might Help Some Stroke Patients 2Health News:Magnetic Brain Stimulation Might Help Some Stroke Patients 3
(Date:5/23/2013)... May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... technology company, today scheduled a conference call to discuss ... year 2013, ended April 30, 2013. The call will ... 2013. The Company will report financial results for the ... close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... 23, 2013 More than half of women ... from chemotherapy and still have excellent outcomes. To educate ... of the largest sources of online consumer information about ... Facebook page provide recently diagnosed women with information sources, ... chemotherapy. "We anticipate these innovative social media ...
(Date:5/23/2013)... May 23, 2013  Texas, premier physician associations today ... the survival tools they need to provide demonstrably better ... health care marketplace. "I am confident the ... practices," said Stephen L. Brotherton , ... Texas doctors are determined to make ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... The Anti-HCV Low Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by manufacturers and ... Comprehensive data from all major test systems ...
... Panel consists of plasma specimens with reactivity ... antibodies to the Hepatitis C Virus., This ... manufacturers and clinical laboratories to evaluate their ... all major test systems are included for ...
... POPmesh is a ... that can be used ... pelvic floor procedures, including ... prolapse. Supple yet strong, ...
Suspend® Tutoplast® Processed Fascia Lata is your naturally safe and strong choice for pelvic floor reconstruction. Suspend comes from a dense matrix of collagen bundles and transverse fasc...
Medicine Products: